Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries, has introduced its most advanced biofuels enzyme, AlternaFuel CMAX. Dyadic says that AlternaFuel CMAX has proven to be effective in converting multiple forms of biomass into fermentable sugars.
Dyadic has developed an integrated technology platform to rapidly discover and express genes of both eukaryotic and prokaryotic origin, then efficiently and inexpensively manufacturing the products of those genes. The company uses a number of proprietary fungal strains to produce enzymes and other biomaterials, principally focused on a system for protein production based on the patented Chrysosporium lucknowense fungus, known as C1. Dyadic has recently completed its scale-up of AlternaFuel CMAX which was derived from Dyadic’s C1 platform technology.
Dyadic’s President and CEO, Mark Emalfarb, will also be presenting the most recent data regarding the performance of AlternaFuel CMAX at the World Biofuels Markets on 23 March at the Biobased Chemicals session and on 24 March at the Advanced Biofuels session.